U.S. Stem Cell, Inc.’s MARVEL Phase II/III Trial Receives Reactivation Status with the FDA – Yahoo Finance
|
U.S. Stem Cell, Inc.'s MARVEL Phase II/III Trial Receives Reactivation Status with the FDA
Yahoo Finance SUNRISE, FL / ACCESSWIRE / April 10, 2017 / U.S. Stem Cell, Inc. (USCC) (USRM), a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therapies for human and animal patients, has received reactivation … |
